Statements (32)
Predicate | Object |
---|---|
gptkbp:instanceOf |
InChIKey
|
gptkbp:brand |
gptkb:Tylenol
gptkb:Panadol gptkb:Paracetamol |
gptkbp:CASNumber |
103-90-2
|
gptkbp:chemicalFormula |
C8H9NO2
|
gptkbp:correspondsTo |
gptkb:paracetamol
|
gptkbp:discoveredIn |
1877
|
gptkbp:excretion |
urine
|
gptkbp:hasSMILES |
CC(=O)NC1=CC=C(O)C=C1
|
gptkbp:hasTherapeuticUse |
analgesic
antipyretic |
https://www.w3.org/2000/01/rdf-schema#label |
RZVAJINKPMORJF-UHFFFAOYSA-N
|
gptkbp:InChIKeyFor |
acetaminophen
|
gptkbp:isApprovedDrug |
true
|
gptkbp:isATCCode |
N02BE01
|
gptkbp:isDrugBankID |
DB00316
|
gptkbp:IUPACName |
N-(4-hydroxyphenyl)acetamide
|
gptkbp:legalStatus |
gptkb:OTC
|
gptkbp:meltingPoint |
168 °C
|
gptkbp:metabolism |
liver
|
gptkbp:molecularWeight |
151.16 g/mol
|
gptkbp:PubChem_CID |
gptkb:CHEMBL112
1983 |
gptkbp:routeOfAdministration |
oral
intravenous rectal |
gptkbp:sideEffect |
liver damage (in overdose)
|
gptkbp:solubility |
14 mg/mL
|
gptkbp:UNII |
362O9ITL9D
|
gptkbp:bfsParent |
gptkb:triphenylphosphine
|
gptkbp:bfsLayer |
7
|